Oncolytics BiotechONCY
13F holders, Q1 2026 (March 31)2holders
$0.85avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Oncolytics Biotech Inc. (ONCY) in their 13F filings. The largest holders were Marshall Wace, LLP ($731K) and Sound Income Strategies, LLC ($180).
- Company
- Oncolytics Biotech Inc.
- CUSIP
- 68237V103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $731K |
| Exits | 0 | $0 |
Ownership 2 holders
| Marshall Wace, LLP | 0.00% | New | 859,831 | $731K |
| Sound Income Strategies, LLC | 0.00% | New | 194 | $180 |
"% of holder's portfolio" is ONCY's weight in each manager's 13F, not the share of Oncolytics Biotech Inc. the manager owns.